A point-of-care brain natriuretic peptide assay in the risk stratification and management of patients with pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 48s Year: 2006
Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 277s Year: 2004
Prognostic role of cardiac troponins and simplified pulmonary embolism severity index in patients with normotensive pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012
Elevated cardiac troponin I levels in acute pulmonary embolism predict increased long-term mortality Source: Eur Respir J 2005; 26: Suppl. 49, 271s Year: 2005
Brain natriuretic peptide in patients with acute pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 270s Year: 2005
Role of brain natriuretic peptide levels in predicting the acute clinical worsening episodes and response to iloprost infusion in patients with pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009
The diagnostic value of cardiac troponins in pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 47s Year: 2006
Comparison of NT-proBNP and BNP in the diagnosis of pulmonary hypertension – influence of renal impairment Source: Eur Respir J 2006; 28: Suppl. 50, 425s Year: 2006
N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism Source: Eur Respir J 2003 Oct 01;22(4):649-653 Year: 2003
Sensitive cardiac troponin I predicts poor outcomes in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 939-944 Year: 2012
Troponin I and risk stratification of patients with acute nonmassive pulmonary embolism Source: Eur Respir J 2008; 31: 847-853 Year: 2008
Evaluation of a new cardiac arrhythmias predictor in patients with COPD Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018
Importance of cardiac biomarkers in the evaluation of acute pulmonary thromboembolism severity, mortality and complicated clinical course Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases Year: 2011
Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension? Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment Year: 2007
Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism Source: Eur Respir J 2014; 43: 1669-1677 Year: 2014
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension Source: Eur Respir J 2010; 35: 1286-1293 Year: 2010
Effect of continuous positive airway pressure on plasma B-type natriuretic peptide in patients with respiratory failure and left ventricular dysfunction complicating acute myocardial infarction Source: Annual Congress 2006 - Acute respiratory failure: diagnostic procedures and clinical management Year: 2006
Prognostic value of echocardiography, BNP and cardiac troponin I (cTnI) in normotensive patients with pulmonary embolism Source: Eur Respir J 2005; 26: Suppl. 49, 271s Year: 2005
Role of B-type brain natriuretic peptide in the development of fluid retention and detection of right ventricular failure in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004
The signifigance of NT-proBNP value pulmonary tromboembolism in early mortality Source: Annual Congress 2006 - Pulmonary embolism Year: 2006